NDA

In addition to Genus’ R&D capabilities, they also benefit from the vast intellectual resources and partnership with foreign companies. Locally in the U.S., chemists, formulation professionals, manufacturing technicians and regulatory specialists also contribute to these efforts.

Genus’ pipeline of new products consists of several NDAs and ANDAs for products in various dosage forms, including tablets, capsules, oral solutions, suspensions, powders, creams and ointments. These new products are at various stages of development, in anticipation of FDA approval, and commercial launch.